跳至主要内容
临床试验/NCT04567446
NCT04567446招募中不适用

Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic

Gustave Roussy, Cancer Campus, Grand Paris9 个研究点 分布在 1 个国家目标入组 1,100 人开始时间: 2018年1月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,100
试验地点
9
主要终点
Overall survival

研究概览

简要总结

Multicentric prospective study with collection of biological samples as part of type II research

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient with cancer who will start treatment anticancer (see cohorts).
  • Patient information and signature of the consent form before any specific procedure for the study. The patient must be able and must be inclined to cooperate in the study procedures.
  • Patient affiliated to a social security scheme or beneficiary of a similar scheme.

排除标准

  • Pregnant or lactating woman
  • Patient under guardianship or curatorship or deprived of liberty by a decision judicial or administrative or patient unable to give his consent.

结局指标

主要结局

Overall survival

时间窗: Up to 2 years

To define metagenomic signatures associated with cancer

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验

Discovery of Microbiome-based Biomarkers for... | 临床试验